<?xml version='1.0' encoding='utf-8'?>
<document id="22139683"><sentence text="Interplay of pharmacogenetic variations in ABCB1 transporters and cytochrome P450 enzymes." /><sentence text="Interindividual variability in oral drug efficacy and toxicity is commonly observed in all therapeutic areas" /><sentence text=" Importantly, interindividual variability in drug uptake and metabolism can result in poor drug response, adverse drug reactions, or unfavorable drug-drug interaction" /><sentence text=" One of the common causes of individual variations in drug response is genetic variation of drug transporters and metabolizing enzymes" /><sentence text=" Pharmacogenetics are rapidly elucidating the inherited nature of these differences in drug disposition and effects, thereby providing a stronger scientific basis for optimizing drug therapy on the basis of each patient's genetic constitution" /><sentence text=" Knowledge of the genotype-phenotype correlation and frequency distribution of functional single nucleotide polymorphisms may be a valuable tool for individualizing drug therapy" /><sentence text=" This information can also be useful for explaining inter-individual and inter-ethnic variations in drug response and/or adverse effects" /><sentence text=" In this review, we focus on the interplay between efflux transporter (ATP-binding cassette, sub-family B (MDR/TAP), member 1/ABCB1) and cytochrome P450s according to genetic polymorphism" /><sentence text="" /></document>